Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig

British Journal of Anaesthesia

Volumn 89, Issue 4, 2002, Pages 599-604

  Ryckwaert, F ^a,b,c   Colson, P ^a,b   Andre E ^a   Perrigault, P F ^a   Guillon, G ^b   Barberis, C ^b  

^a UNIV MONTPELLIER   (France)

^b INSERM   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Arterial pressure, hypertension; Complications, hypervolaemia; Enzymes, angiotensin converting enzyme, inhibition; Hormones, renin; Model, pig

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ATROPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; ISOFLURANE; KETAMINE; MIDAZOLAM; OXYGEN; PLACEBO; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; THIOPENTAL; VALSARTAN;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD VOLUME; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART INDEX; HEMODYNAMICS; HYPOVOLEMIA; MEAN ARTERIAL PRESSURE; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZATION; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SWINE; SYSTEMIC VASCULAR RESISTANCE; TIME;

EID: 0036794422     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aef221     Document Type: Article

References (25)

1. Breckenridge A. Angiotensin converting enzyme inhibitors. Br Med J 1988; 396: 618-20.
2. Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med 1996; 334: 1649-54
3. Kiowski W, Linder L, Kleinbloesem C, Kleinbloesem C, van Brummelen P, Bühler FR. Blood pressure control by the renin-angiotensin system in normotensive subjects. Circulation 1992; 85: 1-8
4. Sancho J, Re R, Burton J, Barger AC, Haber E. The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects. Circulation 1976; 53: 400-5
5. Haber E. The role of renin in normal and pathological cardiovascular homeostasis. Circulation 1976; 54: 849-61
6. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52: 415-72
7. Colson P, Ryckwaert F, Coriat P. Renin angiotensin system antagonists and anesthesia. Anesth Analg 1999; 89: 1143-55
8. Carp H, Vadhera R, Jayaram A, Garvey D. Endogenous vasopressin and renin-angiotensin systems support blood pressure after epidural block in humans. Anesthesiology 1994; 80: 1000-7
9. Coriat P, Richer C, Douraki T, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994; 81: 299-307
10. Colson P, Saussine M, Séguin JR, Cuchet D, Chaptal PA, Roquefeuil B. Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1992; 74: 805-8
11. Brabant S, Bertrand M, Eyraud D, Darmon PL, Coriat P. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg 1999; 88: 1388-92
12. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998; 83: 1182-91
13. Eyraud D, Brabant S, Dieudonne N, et al. Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anesth Analg 1999; 88: 980-4
14. Schadt JC, Ludbrook J. Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. Am J Physiol 1991; 260: H305-18
15. Courneya CA, Korner PI. Neurohumoral mechanisms and the role of arterial baroreceptors in the reno-vascular response to haemorrhage in rabbits. J Physiol 1991; 437: 393-407
16. Cox Rh, Bagshaw RJ. Effects of anesthesia on carotid sinus reflex control of arterial hemodynamics in the dogs. Am J Physiol 1980; 239: H681-91
17. Oliver JR, Korner PI, Woods RL, Zhu JL. Reflex release of vasopressin and renin in hemorrhage is enhanced by autonomic blockade. Am J Physiol 1990; 258: H221-8
18. Korner PI, Oliver JR, Zhu JL, Woods RL. Autonomic, hormonal, and local circulatory effects of hemorrhage in conscious rabbits. Am J Physiol 1990; 258: H229-39
19. Chung O, Kuhl H, Stoll M, Unger T. Physiological and pharmacological implications of AT1 versus AT2 receptors. Kidney Int Suppl 1998; 67: S95-9
20. Scheuer DA, Perrone MH. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am J Physiol 1993; 264: R917-23
21. Ichiki T, Labosky PA, Shiota C, et al. Effects on blood pressure and explanatory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377: 748-50
22. Siragy HM. The role of AT2 receptor in hypertension. Am J Hypertens 2000; 13: 62S-67S
23. Bindschedler M, Degen P, Flesch G, de Gasparo M. Pharmacokinetic and pharmacodynamic interaction of single oral doses of valsartan and furosemide. Eur J Clin Pharmacol 1997; 52: 371-8
24. Bertrand M, Godet G, Meerschaert K, Brun L, Salcedo E, Coriat P. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg 2001; 92: 26-30
25. Ryckwaert F, Colson P. Hemodynamic effects of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1997; 84: 945-9